# Covid-19 Thread: 2023 Breaking News **URL:** https://boards.straightdope.com/t/covid-19-thread-2023-breaking-news/977610 **Category:** The Quarantine Zone **Tags:** covid-quarantine **Created:** [January 3, 2023, 11:12pm UTC](https://boards.straightdope.com/t/covid-19-thread-2023-breaking-news/977610 "2023-01-03T23:12:31Z") **Posts on this page:** 1 **Showing post:** 56
### Author: ![bordelond](https://sea3.discourse-cdn.com/straightdope/user_avatar/boards.straightdope.com/bordelond/32/150_2.png) [@bordelond](https://boards.straightdope.com/u/bordelond) #### Post date: [May 4, 2023, 5:51pm UTC](https://boards.straightdope.com/t/covid-19-thread-2023-breaking-news/977610/56 "2023-05-04T17:51:44Z")
Being able to combat the fatigue symptoms common to long COVID would make a life-changing difference for many thousands: > This is one of the first randomized double-blind placebo-controlled trials of a potential long COVID treatment - AXA1125. Randomized control trials are considered to be gold standard for testing potential treatments for an illness. > > People living with long COVID in the trial who received AXA1125 had a significant improvement in fatigue compared to those who received a placebo (material matched in appearance and taste to the investigational treatment). The study was double-blind, that is, neither the patients nor the researchers working with the patients knew which patients had the treatment and which patients had a placebo. > **[Researchers report positive results from Phase 2 clinical trial of...](https://www.news-medical.net/news/20230503/Researchers-report-positive-results-from-Phase-2-clinical-trial-of-investigational-treatment-against-long-COVID-fatigue.aspx)** > > Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue. --- _[View the full topic](https://boards.straightdope.com/t/covid-19-thread-2023-breaking-news/977610)._